Use of ursodeoxycholic acid in patients with liver disease (Q34515643)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Use of ursodeoxycholic acid in patients with liver disease	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11825540

retrieved

2 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Use of ursodeoxycholic acid in patients with liver disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11825540

retrieved

2 August 2017

author name string

Paul Angulo

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11825540

retrieved

2 August 2017

publication date

1 February 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11825540

retrieved

2 August 2017

published in

Current gastroenterology reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11825540

retrieved

2 August 2017

volume

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11825540

retrieved

2 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11825540

retrieved

2 August 2017

page(s)

37-44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11825540

retrieved

2 August 2017

cites work

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11894-002-0036-9

retrieved

21 January 2018

A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cholestasis and bile acids on interferon-induced 2′, 5′-adenylate synthetase and NK cell activities

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Nordic multicenter double-blind randomized controlled trial of prophylactic ursodeoxycholic acid in liver transplant patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of ATP secretion in the liver by therapeutic bile acids

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of ursodeoxycholic acid to prevent acute cellular rejection after liver transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of hepatitis C: Other options

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of nonalcoholic fatty liver: present and emerging therapies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of ursodeoxycholic acid, an enterohepatic drug.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized, double-blind trial evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized double-blind study controlled with placebo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ursodeoxycholate increases cytosolic calcium concentration and activates CI− currents in a biliary cell line

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11825540

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11894-002-0036-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11825540

retrieved

2 August 2017

Dimensions Publication ID

1030509893

0 references

PubMed publication ID

11825540

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11825540

retrieved

2 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34515643&oldid=2196730194"